UPDATE: 4D Molecular Therapeutics Q4 EPS $0.43 Beats $(0.53) Estimate, Sales $85.090M Beat $32.245M Estimate
4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $(0.53) by 181.13 percent. This is a 147.78 percent increase over losses of $(0.90) per
